DKK4 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9UBT3 |
---|---|
Clone Names | 101008260 |
Gene ID | 27121 |
---|---|
Other Names | Dickkopf-related protein 4, Dickkopf-4, Dkk-4, hDkk-4, Dickkopf-related protein 4 short form, DKK4 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | DKK4 |
---|---|
Function | Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease (By similarity). |
Cellular Location | Secreted. |
Tissue Location | Expressed in cerebellum, T-cells, esophagus and lung |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a protein that is a member of thedickkopf family. The secreted protein contains two cysteine richregions and is involved in embryonic development through itsinteractions with the Wnt signaling pathway. Activity of thisprotein is modulated by binding to the Wnt co-receptor and theco-factor kremen 2.
References
Hosgood, H.D. III, et al. Occup Environ Med 66(12):848-853(2009)Yerges, L.M., et al. J. Bone Miner. Res. 24(12):2039-2049(2009)Hirata, H., et al. Cancer 115(19):4488-4503(2009)Matsui, A., et al. Cancer Sci. 100(10):1923-1930(2009)Baehs, S., et al. Cancer Lett. 276(2):152-159(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.